Prolonged hemostatic ability of polyethylene glycol–modified polymerized albumin particles carrying fibrinogen γ‐chain dodecapeptide

Abstract

H12-PEG-polyAlb may be a suitable candidate for treatment of bleeding into thrombocytopenic patients as an alternative to PLT concentrate transfusion.